Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?
出版年份 2018 全文链接
标题
Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 22, Issue 7, Pages 587-598
出版商
Informa UK Limited
发表日期
2018-06-12
DOI
10.1080/14728222.2018.1486823
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease
- (2018) Na Zhao et al. BIOLOGICAL PSYCHIATRY
- Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
- (2018) Wilbur M. Song et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased Expression of TREM2 in Peripheral Blood of Alzheimer's Disease Patients
- (2018) Nan Hu et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
- (2018) Anna Antonell et al. JOURNAL OF ALZHEIMERS DISEASE
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
- (2017) Susanne Krasemann et al. IMMUNITY
- Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer’s Disease Pathology Between Three Independent Assay Platforms
- (2017) James D. Doecke et al. JOURNAL OF ALZHEIMERS DISEASE
- A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells
- (2017) Megan M. Varnum et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TREM2-Ligand Interactions in Health and Disease
- (2017) Daniel L. Kober et al. JOURNAL OF MOLECULAR BIOLOGY
- Triggering Receptor Expressed on Myeloid Cells 2 Deficiency Alters Acute Macrophage Distribution and Improves Recovery after Traumatic Brain Injury
- (2017) Maha Saber et al. JOURNAL OF NEUROTRAUMA
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease
- (2017) Valentina Escott-Price et al. NEUROBIOLOGY OF AGING
- Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer’s disease
- (2017) Luke W. Bonham et al. NEUROCASE
- TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
- (2017) Cheryl E. G. Leyns et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current status of treating neurodegenerative disease with induced pluripotent stem cells
- (2016) A. E. Pen et al. ACTA NEUROLOGICA SCANDINAVICA
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
- (2016) Juan Domingo Gispert et al. Alzheimers & Dementia
- TREM2 p.H157Y Variant and the Risk of Alzheimer's Disease: A Meta-Analysis Involving 14,510 Subjects
- (2016) Teng Jiang et al. CURRENT NEUROVASCULAR RESEARCH
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Neuroprotective Effect of TREM-2 in Aging and Alzheimer’s Disease Model
- (2016) Animesh Alexander Raha et al. JOURNAL OF ALZHEIMERS DISEASE
- TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
- (2016) Yaming Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
- (2016) Taylor R. Jay et al. JOURNAL OF NEUROSCIENCE
- Accelerating stem cell trials for Alzheimer's disease
- (2016) Joshua G Hunsberger et al. LANCET NEUROLOGY
- TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice
- (2016) Teng Jiang et al. MOLECULAR NEUROBIOLOGY
- Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
- (2016) Li Ma et al. Molecular Neurodegeneration
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone
- (2016) Annika Öhrfelt et al. Multiple Sclerosis Journal
- A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese
- (2016) Teng Jiang et al. NEUROBIOLOGY OF AGING
- Assessment of the genetic variance of late-onset Alzheimer's disease
- (2016) Perry G. Ridge et al. NEUROBIOLOGY OF AGING
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
- (2016) Peng Yuan et al. NEURON
- TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
- (2016) Felix L. Yeh et al. NEURON
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Vps35-dependent recycling of Trem2 regulates microglial function
- (2016) Jie Yin et al. TRAFFIC
- Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
- (2016) Rik Vandenberghe et al. Alzheimers Research & Therapy
- Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone
- (2016) Annika Öhrfelt et al. Multiple Sclerosis Journal
- TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation
- (2016) Huaili Jiang et al. Scientific Reports
- TREM2 regulates microglial cell activation in response to demyelination in vivo
- (2015) Claudia Cantoni et al. ACTA NEUROPATHOLOGICA
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
- (2015) Yuka Atagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TREM2 deficiency eliminates TREM2+inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
- (2015) Taylor R. Jay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke
- (2015) M. Kawabori et al. JOURNAL OF NEUROSCIENCE
- TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
- (2015) Sheng Chih Jin et al. Molecular Neurodegeneration
- Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus
- (2015) Ji-Seon Park et al. TRAFFIC
- Microglia: Dynamic Mediators of Synapse Development and Plasticity
- (2015) Yuwen Wu et al. TRENDS IN IMMUNOLOGY
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
- (2014) Oscar Harari et al. BIOLOGICAL PSYCHIATRY
- TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices
- (2014) Lih-Fen Lue et al. BRAIN PATHOLOGY
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Human-induced pluripotent stem cells: potential for neurodegenerative diseases
- (2014) C. A. Ross et al. HUMAN MOLECULAR GENETICS
- Coding variants in TREM2 increase risk for Alzheimer's disease
- (2014) Sheng Chih Jin et al. HUMAN MOLECULAR GENETICS
- Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
- (2014) Jason D Ulrich et al. Molecular Neurodegeneration
- Microglial CR3 Activation Triggers Long-Term Synaptic Depression in the Hippocampus via NADPH Oxidase
- (2014) Jingfei Zhang et al. NEURON
- Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease
- (2014) Teng Jiang et al. NEUROPSYCHOPHARMACOLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- Never-resting microglia: physiological roles in the healthy brain and pathological implications
- (2014) Amanda Sierra et al. Frontiers in Cellular Neuroscience
- TREM2 and the neuroimmunology of Alzheimer's disease
- (2013) Suzanne E. Hickman et al. BIOCHEMICAL PHARMACOLOGY
- Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor
- (2013) Christopher N. Parkhurst et al. CELL
- Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases
- (2013) Christopher J Pelham et al. Expert Review of Clinical Immunology
- Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
- (2013) Patrick Wunderlich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
- (2013) Sruti Rayaprolu et al. Molecular Neurodegeneration
- Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease
- (2013) Margarita Giraldo et al. NEUROBIOLOGY OF AGING
- A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family
- (2013) Rita Guerreiro et al. NEUROBIOLOGY OF AGING
- TREM2 is associated with the risk of Alzheimer's disease in Spanish population
- (2013) Bruno A. Benitez et al. NEUROBIOLOGY OF AGING
- Heterozygous TREM2 mutations in frontotemporal dementia
- (2013) Barbara Borroni et al. NEUROBIOLOGY OF AGING
- Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia
- (2013) Elise Cuyvers et al. NEUROBIOLOGY OF AGING
- Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease
- (2013) Kurt M. Lucin et al. NEURON
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microglia: actively surveying and shaping neuronal circuit structure and function
- (2012) Hiroaki Wake et al. TRENDS IN NEUROSCIENCES
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor
- (2009) Luisa Stefano et al. JOURNAL OF NEUROCHEMISTRY
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
- (2008) Laura Piccio et al. BRAIN
- Mutations inTREM2lead to pure early-onset dementia without bone cysts
- (2008) Eliane Chouery et al. HUMAN MUTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search